Menu Search
Equities

Feedback PLC

GZM0:FRA

Feedback PLC

Actions
  • Price (EUR)0.238
  • Today's Change-0.022 / -8.46%
  • Shares traded2.00k
  • 1 Year change-72.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. The Company has a number of growth opportunities domestically and internationally across a range of markets.

  • Revenue in GBP (TTM)1.18m
  • Net income in GBP-3.30m
  • Incorporated1958
  • Employees24.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.